Content about Amphetamines

December 2, 2011
ABC's 'Nightline' shadows three meth busts

ABC's "Nightline: Late Evening News" on Wednesday aired an exposé on Kentucky's methamphetamine problem, shadowing law enforcement as they made three arrests in a state that employs an electronic tracking system for the over-the-counter ingredient pseudoephedrine. The officers investigated sales made at Walgreens, CVS and Walmart.

November 2, 2011
Report: Meth cooks credited with 80% increase in PSE sales

There has been a sharp increase in sales of pseudoephedrine products just outside St. Charles County, Mo., which implemented a prescription requirement on the sale of PSE beginning Aug. 30, according to an article in the St. Louis Post-Dispatch published Monday.

October 11, 2011
Reports: ONDCP deputy director advocates Rx-only for PSE

The debate on the prescription status of pseudoephedrine in the state of Kentucky heated up last week as the deputy director of the White House Office of National Drug Control Policy Benjamin Tucker on Wednesday told Kentucky lawmakers that they should mandate PSE to Rx-only status, according to reports.

September 22, 2011
Orexigen, FDA work out plan for path to approval of obesity drug

Drug maker Orexigen Therapeutics said it had identified a "clear and feasible path" for the approval of its drug for treating obesity by working with the Food and Drug Administration.

September 13, 2011
Survey: Meth use down, thanks to services like NPLEx

Methamphetamine use is down by 50%, even as use of illicit drugs continued to climb between 2008 and 2010, according to a national survey conducted by the Substance Abuse and Mental Health Services Administration that was released last week.

July 8, 2011
Watson seeks FDA approval for generic Vyvanse

Watson Pharmaceuticals has filed with the Food and Drug Administration for regulatory approval for a drug to treat attention deficit hyperactivity disorder, the company said Thursday.

July 5, 2011
Shire files suit against Amneal, Sandoz over generic Vyvanse

Shire has filed patent infringement suits against two generic drug makers relating to its attention deficit hyperactivity disorder treatment.

June 17, 2011
CHPA praises North Carolina's passage of PSE sales blocking technology legislation

The North Carolina legislature passed a real-time, stop-sale system, which allows law-abiding citizens to access medicines containing pseudoephedrine, while stopping sales that exceed the legal limit.

June 14, 2011
Cypress gets OK for cough-cold medications Zutripro, Rezira

The Food and Drug Administration has approved two cough-cold medications made by Cypress Pharmaceutical, the company said Monday.

May 20, 2011
Sandoz looks to market generic Vyvanse

Sandoz is looking to market a generic version of a Shire drug for treating attention deficit hyperactivity disorder.

May 11, 2011
Missouri's Rx-only PSE legislation moves to state Senate

Missouri’s House of Representatives on Monday voted 100 in favor and 50 opposed to reclassifying pseudoephedrine as a prescription-only remedy and subsequently moved the matter to the state Senate.

April 25, 2011
Target touts pharmacists’ expertise

Target is encouraging customers to direct their sights toward its in-store pharmacies with its “Ask Us” campaign. The campaign includes signage located throughout the store designed to direct shoppers to seek information from pharmacists about everything from allergies to generic discounts, promoting Target’s pharmacists as experts on medicines.


The signage includes floor graphics in the aisles leading to the pharmacy counter, signs hanging from ceilings and placards posted on endcaps. 


April 18, 2011
Report: Kansas makes switch to NPLEx system to track pseudoephedrine sales

Kansas on Monday officially made the move from a paper tracking system for pseudoephedrine sales to the electronic tracking capabilities afforded through the National Precursor Log Exchange, according to an Associated Press report published Monday.

April 13, 2011
Georgia seeks to restrict PSE product sales to pharmacies

A bill passed by the Georgia House of Representatives Tuesday will restrict the sale of products containing pseudoephedrine to only pharmacies — a factor that will eliminate PSE products for sale at any gas stations, convenience stores and mass merchants/supermarkets without a pharmacy.

April 6, 2011
Shire files lawsuit against Watson over Adderall XR

British drug maker Shire has filed suit against Watson Pharmaceuticals and subsidiaries, alleging patent infringement in a case concerning a drug used to treat attention deficit hyperactivity disorder.

March 25, 2011
The Big 3

There are three issues involving over-the-counter medicines today that have put the industry on the defensive, and all involve the question of appropriate access. Drug Store News examined each.

1. FLEXIBLE SPENDING ACCOUNTS The issue: The Patient Protection and Affordable Care Act required that FSA participants obtain a prescription for those OTCs incorporated into their health savings agenda.

March 18, 2011
PSE's Rx-only switch in Arkansas opens a new can of worms

The latest Arkansas proposition to control PSE sales may deliver the biggest blow to the over-the-counter accessibility argument, as it restricts sales to Arkansas residents who have a state-issued picture ID and who don’t look like they might be meth addicts. It also is no more fair or effective to have pharmacists decide who looks like a meth addict and who doesn't. Worse, the bill includes a provision that would allow the Arkansas Board of Pharmacy to color any OTC medicine with the same brush as PSE.

March 17, 2011
Arkansas PSE bill could spark fresh debate

SB 437, a bill passed Wednesday by the Arkansas House by a vote of 60-31, introduces a number of new issues to the debate on whether or not pseudoephedrine and similar ingredients should be sold behind the counter or by prescription only.

March 17, 2011
Report: Arkansas House passes pharmacist-only PSE bill

The Arkansas House on Wednesday passed a bill that would restrict the behind-the-counter sale of pseudoephedrine to pharmacists only. In other words, pharmacy technicians no longer would be allowed to sell products containing PSE.

March 4, 2011
Allergy: Arkansas considers PSE switch to Rx-only

As Drug Store News suggested last month, legislation under consideration in Tennessee and Kentucky that would make the popular decongestant pseudoephedrine only available by prescription has, in fact, sparked interest in neighboring states.

February 25, 2011
Watson seeks regulatory approval for generic Adderall XR

Watson Labs is hoping to be the first to market a generic version of a popular drug for attention deficit hyperactivity disorder.

February 23, 2011
Study: Amphetamine use could pose Parkinson's disease risk

Use of amphetamines could increase the risk of Parkinson’s disease, according to a new study.

February 22, 2011
Report: Arkansas considers switching PSE to Rx only

Arkansas on Friday became the fourth state this year to entertain making the popular decongestant pseudoephedrine available only by prescription.

February 18, 2011
First half of cold season ends with H1N1 hangover

All the hype around H1N1 
that was so prevalent in 2009 is gone, leaving only the tough comparisons a year later.

February 18, 2011
Tennessee latest 
to fight PSE status

NASHVILLE, Tenn. — Tennessee makes the third state this year, joining Kentucky and Nevada, that is considering state legislation to mandate the sale of pseudoephedrine as prescription-only. That could prove a big concern for the legitimate market for PSE products on account of the potential snowball effect such legislation could have on neighboring states. According to a government review staff in Kentucky, at least 97.8% of all PSE sales are bought for legitimate use.

© 2013 Drug Store News. All Rights Reserved.